https://www.selleckchem.com/products/fht-1015.html
BACKGROUND This study directs to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone versus IMRT plus chemotherapy in intermediate-risk NPC (stage II and T3N0M. METHODS A total of 124 patients with stage II and T3N0M0 NPC were pair-matched (11 ratio) to form two groups an IMRT-alone group and an IMRT/chemotherapy group. Survival outcomes (overall survival [OS], disease-free survival [DFS], locoregional relapse-free survival [LRRFS], distant metastasis-free survival [DMFS]) and treatment-related grade 3-4
Tycka om
Kommentar
Dela med sig
